Mendelian randomization in Alzheimer's disease and mild cognitive impairment: Hippocampal volume associations

Jianguo Zhou1, Lei Gong2, Xiaoli Liu3

  • 1Department of Radiology, Lianyungang Affiliated Hospital of Nanjing University of Chinese Medicine, Lianyungang 222004, PR China.

Neuroscience
|October 5, 2024
PubMed

Insights

This study found significant hippocampal volume reductions in Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) patients. However, Mendelian randomization did not establish a causal link between hippocampal volume and Alzheimer's Disease progression.

Area of Science:

  • Neuroscience
  • Genetics
  • Medical Imaging

Background:

  • Cognitive dysfunction is a hallmark of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI).
  • Hippocampal volume reduction is frequently observed in neurodegenerative conditions, but its causal role remains unclear.

Purpose of the Study:

  • To investigate the association between cognitive dysfunction and hippocampal volumes in AD and MCI.
  • To explore the causal relationship using Mendelian randomization.

Main Methods:

  • Meta-analysis of neuroimaging data from healthy controls, MCI patients, and AD patients.
  • Mendelian randomization analysis to assess causality.

Main Results:

  • Significant reductions in hippocampal and subregion volumes were observed in MCI and AD patients compared to controls.
  • No causal relationship was established between hippocampal volume and AD via Mendelian randomization.

Conclusions:

  • Hippocampal volume reduction is a significant finding in MCI and AD.
  • The direct causal link between hippocampal volume and Alzheimer's Disease requires further investigation.